GoKawiilThank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Dynamics of circulating tumour DNA can guide treatment decisions for improved outcomes
Why This Matters
Understanding the dynamics of circulating tumour DNA (ctDNA) offers a promising approach for personalized cancer treatment, enabling more precise and timely decisions that can improve patient outcomes. This advancement highlights the potential for integrating advanced genomic technologies into routine clinical practice, transforming cancer care. For consumers, it means more tailored therapies with potentially better efficacy and fewer side effects.
Key Takeaways
- ctDNA dynamics can guide personalized treatment decisions
- Improves accuracy of monitoring cancer progression
- Supports development of targeted therapies
Explore topics:
circulating tumour dna
treatment decisions
cancer diagnostics
genomics
precision medicine
Get alerts for these topics